Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2003
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186991 Polymerases enzyme inihibtor
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186979 Hydroxyformamidine derivatives and medicines containing the same
10/02/2003US20030186968 Psychological disorders; central nervous system disorders
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186944 Novel aromatic compounds
10/02/2003US20030186924 Prodrugs
10/02/2003CA2780743A1 Substituted tetracycline compounds
10/01/2003EP1349005A1 Photosensitive compound, resin and composition
10/01/2003EP1348700A2 Composition and method for dyeing dye-susceptible material
10/01/2003EP1348699A1 Process for the preparation of 2-chloro-5-methylpyridine-3-carbaldehyde
10/01/2003EP1348698A1 Substituted carboxylic acid derivatives
10/01/2003EP1348435A1 Preparation process of pure form (II) 1-isopropyl-3-[(4-M toluidino-3-pyridyl) sulphonyl]-urea (Torasemide) and pharmaceutical preparations thereof
10/01/2003EP1347961A1 A process for the preparation of a collidine and 2,3,5,6-tetramethyl pyridine
10/01/2003EP1347952A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP1347784A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
10/01/2003EP1001944B1 Pyrazine derivatives, preparation and medicines containing them
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0813525B1 Benzamidine derivatives their preparation and their use as anti-coagulants
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1445216A Nicotinic acid ester of resveratrol and its synthetic method
10/01/2003CN1122665C Herbicidal N-alkenyl heteroaryloxyacetamides
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627758 Ligand including (i) at least two different types of heteroatoms selected from nitrogen, phosphorus, and sulfur, and (ii) at least one of imidazole, pyrazole, and pyridine; transition metal complex for carbonylation to aldehyde
09/30/2003US6627742 Hydroxypyridonemethide azo dyes
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627648 Pharmaceutical compositions and methods for use
09/28/2003CA2379370A1 Carboxylic acid derivatives of 3-hydroxy-4-oxo-1,4-dihydropyridine as iron chelators
09/27/2003CA2423550A1 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078396A1 Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
09/25/2003WO2003078386A1 Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof
09/25/2003WO2003078384A1 Multidentate ligand, multi-nucleus metal complex, metal complex chain, metal complex integrated structure, and preparation method thereof
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003077727A2 Technetium-dipyridine complexes, and methods of use thereof
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease
09/25/2003WO2002074733A3 Tryptase-inhibitors
09/25/2003US20030181759 Reacting a benzoic acid with a halogenating agent in presence of palladium catalyst to form halogenated benzoic acid or derivatives
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181718 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/25/2003US20030181717 R-isomers of nonnucleoside inhibitors
09/25/2003US20030181688 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
09/25/2003US20030181492 Administering amine, mercaptan or acid derivatives of benzene or pyridine for
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181485 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
09/25/2003US20030181484 New substituted pyridine or piperidine compounds
09/25/2003US20030181442 Carbamides such as N-(3-tert-butylphenyl)-N'-(4-(3-(N-methyl-carbamoyl)phenoxy)phenyl urea, used as enzyme inhibitors and as anticarcinogenic agents
09/25/2003US20030181422 Cardioprotective phosphonates and malonates
09/25/2003US20030181420 Modulators of LXR
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181334 Herbicidal method
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/25/2003CA2477886A1 Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
09/24/2003EP1346984A1 Process for the preparation of 2-chloro-5-methylpyridine-3- carbaldehyde
09/24/2003EP1345906A2 Method for producing 4-haloalkyl nicotine nitriles
09/24/2003EP1345905A1 Potassium channel inhibitors
09/24/2003EP1345904A1 Dichloropyridyl methyl cyanamidines
09/24/2003EP1345903A1 Crystalline forms of cerivastatin sodium
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345494A2 Dichloropyridyl methylamides
09/24/2003EP1054868B1 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0977736B1 Process for preparing pure flupirtin maleate and its modification a
09/24/2003EP0961770B1 Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine
09/24/2003CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1443758A Coupled tert-butyl pyridine, its synthesis method and application
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1122024C Process for converting hydroxy heteroaromatics to arylamines
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624308 Method of production and method of separation of 2,4′-dipyridyl derivatives and methods of production of benzoxazepine derivatives and salts thereof
09/23/2003US6624307 Process for producing 2,6-dihydroxy-3,4-dialkylpyridines
09/23/2003US6624196 Particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of multiple sclerosis, cardiovascular disorders
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076938A1 Novel fluorescent label compounds
1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 633